Project 2025 vs. the Public's Health Part II: The FDA

MicrobeTV

P. Offit, V. Racaniello

Walking Pneumonia, the Beginning of Influenza Season, and Does Antiv…

MicrobeTV

D. Griffin, V. Racaniello

What to Know About the FDA Authorization and Approval of Updated COV…

Amesh Adalja

Preparing for Winter: CDC Recommendations for Influenza, COVID-19, a…

Diego Hijano

Project 2025 vs. the Public's Health Part III: The NIH

MicrobeTV

P. Offit, V. Racaniello

CHEST 2024 Insights: Vaccination Challenges and Strategies for Viral…

CHEST Annual Meeting Insights

A. Kapoor

What's New with COVID in 2024?

Michigan Medicine

L. Washer

ACAAI 2024 Insights: Secondary Immunodeficiency - Management Strateg…

ACAAI 2024 Insights

S. Mustafa

Herpes Zoster: Prevention and Management

Stephanie James

IDSA Guidelines for Using Anti-SARS-CoV-2 Monoclonal Antibody Therap…

MicrobeTV

D. Griffin, V. Racaniello

Emergency Use Authorization for Updated COVID Vaccine, West Nile Vir…

MicrobeTV

D. Griffin, V. Racaniello

Project 2025 vs. The Public’s Health Part I: The CDC

MicrobeTV

P. Offit, V. Racaniello

Durability of Protection Following Administration of Recombinant Ant…

MicrobeTV

D. Griffin, V. Racaniello

IDWeek 2024 Insights: COVID-19 in Children - Navigating the Current …

IDWeek 2024 Insights

I. Anosike

September 2024 Public Health Infectious Disease Updates

California Medical Association

E. Pan

IDWeek 2024 Insights: Management of Substance Use Disorders in HIV

IDWeek 2024 Insights

H. Hurley

Update on Adult Immunizations (July 2024): Part 1

Barbara Yawn

Update on Adult Immunizations (July 2024): Part 2

Barbara Yawn

Recent ACIP Recommendations for RSV Vaccines for Patients Over 60, T…

MicrobeTV

D. Griffin, V. Racaniello

CDC Guidelines for Seasonal Influenza Vaccines, How and When to Use …

MicrobeTV

D. Griffin, V. Racaniello